In the next couple years we should have Hep B, Lung cancer, AMD, and OPMD in the clinic. This should be trading much higher by then. Just sit back and relax is my motto.
MKT The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint